Recently, our research group demonstrated in two experimental models that muscles with abnormal [Ca2+]i exhibit a reduction in glucose-dependent insulin transport and that reducing [Ca2+]i transforms muscles from insulin-resistant to non-insulin-resistant, with a subsequent improvement in hyperglycemia [4]. This evidence concerns the gene INS and Hyperglycemia.